retatrutide triple agonist glp-1 gip glucagon ly3437943 Guide 2023: Weight Loss, Benefits, Results, Dosage Retatrutide (LY3437943): Mechanism of Action

With the rising incidence of obesity, there is a growing demand for new therapies which can effectively manage body weight and improve health

National Taiwan University researchers highlight the benefits of GLP-1 receptor agonists (GLP-1 RAs) in reducing mortality and severe cardiovascular and renal outcomes for diabetic patients with acute kidney disease (AKD)

This study investigates the effects of allulose, a rare sugar shown to reduce blood glucose, in a rat model of diet-induced obesity and T2D

Supports overall daily wellness

The incretin hormone glucagon-like peptide 1 (GLP-1) has been implicated in the gutrenal axis and incretin-based therapies might reduce the burden of diabetic kidney disease

Triple agonist (GLP-1/GIP/Glucagon), under clinical investigation